Former Chief Commercial Officer and Head of International · Trevi Therapeutics, Inc. (TRVI)

Yann Mazabraud

A named executive officer of Trevi Therapeutics in every fiscal year CompBrief holds from FY2018 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$716,856

Salary $302,388Stock awards $0

FY2019: $914,666

2nd of 4 named executive officers at Trevi Therapeutics by FY2020 total.

4 named officers on file for Trevi Therapeutics, FY2020

Yann Mazabraud’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • TRVI’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Trevi Therapeutics’s whole pay program stands against its peers

  • Trevi Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TRVI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2021 (DEF 14A).

Free

Get Yann Mazabraud’s full pay file as a PDF — free

More than this page: up to 10 years of Yann’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Yann Mazabraud compensation by year

Trevi Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Trevi Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020
Salary$185,317$325,736$302,388
Bonus$35,162$83,868$0
Stock awards$0$0$0
Option awards$571,167$358,517$272,585
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$221,187$146,545$141,883
Total$1,012,833$914,666$716,856

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Trevi Therapeutics, Inc. DEF 14A filed April 27, 2021, accession 0001193125-21-134252, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Trevi Therapeutics, Inc. filed document, accession 0001193125-21-134252. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2021.

$1.0M
$915K
$717K
FY18
FY19
FY20
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option2,632—$3.33
Option63,655—$9.12
Option50,000—$10.12

Per the Outstanding Equity Awards at Fiscal Year-End table in Trevi Therapeutics, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Trevi Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Jennifer GoodPresident and Chief Executive Officer$1,441,457
Yann Mazabraud · this pageFormer Chief Commercial Officer and Head of International$716,856
Chris SeiterFormer Chief Financial Officer$716,218
Thomas SciasciaChief Medical Officer$709,894

The full Trevi Therapeutics compensation record

free company brief

This page is one person within Trevi Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Trevi Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Trevi Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Yann Mazabraud's compensation dossier · One-time report. No refunds.